title: Aerosolization of protein solutions using thermal inkjet technology.
abstract: Vapotronics Inc. is developing the thermal inkjet (TIJ) technology used extensively in the printer industry to create a digital aerosol inhaler for the inhalation of therapeutics for local and systemic delivery. The operation of thermal inkjet printers requires generation of high temperatures and vaporization of the liquid formulation to effect droplet ejection. A study was conducted to develop formulations that would permit the generation of aerosols of therapeutic proteins without damage to the inkjet system or degradation of the proteins. Two proteins, human growth hormone and insulin, were formulated and aerosolized. The aerosol was collected and subjected to assays to compare the physicochemical and biological activities of these proteins before and after aerosolization. In each case, there was no significant changes to the proteins as a result of the aerosolization, providing evidence that TIJ can be used for aerosolizing solutions of protein therapeutics.
authors.affiliation: Vapotronics Limited, Clunies Ross Centre, Eight Mile Plains, Queensland Australia. goodall@powerup.com.au
authors.forename: Stephen
authors.initials: S
authors.lastname: Goodall
authors.forename: Nora
authors.initials: N
authors.lastname: Chew
authors.forename: Kim
authors.initials: K
authors.lastname: Chan
authors.forename: Dion
authors.initials: D
authors.lastname: Auriac
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Waters
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D019382:Human Growth Hormone / Q000008:administration & dosage*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*; D009330:Nebulizers and Vaporizers; D010316:Particle Size; D011327:Printing
chemical_list: D000336:Aerosols; D007328:Insulin; D019382:Human Growth Hormone